|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||
| Current assets | |||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||
| Accounts receivable, net of credit losses of $127 and $186 at March 31, 2025 and December 31, 2024, respectively | |||||||||||||||||
| Prepaid expenses | |||||||||||||||||
| Other current assets | |||||||||||||||||
| Total current assets | |||||||||||||||||
| Capitalized software development costs, net | |||||||||||||||||
| Goodwill | |||||||||||||||||
| Intangible assets, net | |||||||||||||||||
| Operating lease right-of-use assets, net | |||||||||||||||||
| Other assets | |||||||||||||||||
| Total assets | |||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT) | |||||||||||||||||
| Current liabilities | |||||||||||||||||
| Accounts payable | |||||||||||||||||
| Accrued compensation and benefits | |||||||||||||||||
| Accrued expenses | |||||||||||||||||
| Accrued content license fees | |||||||||||||||||
| Liabilities to users | |||||||||||||||||
| Current operating lease liabilities | |||||||||||||||||
| Other current liabilities | |||||||||||||||||
| Total current liabilities | |||||||||||||||||
| Deferred income taxes | |||||||||||||||||
| Long-term debt | |||||||||||||||||
| Content licensing liabilities | |||||||||||||||||
| Non-current operating lease liabilities | |||||||||||||||||
| Other liabilities | |||||||||||||||||
| Total liabilities | |||||||||||||||||
| Shareholders’ equity (deficit) | |||||||||||||||||
| Ordinary shares, $0.01 par value, 100,000,000 shares authorized, 46,153,365 and 45,071,578 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | |||||||||||||||||
| Additional paid-in capital | |||||||||||||||||
| Accumulated deficit | |||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||
| Total shareholders’ deficit | |||||||||||||||||
| Total liabilities and shareholders’ equity (deficit) | |||||||||||||||||
Loading...
